These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 27251645)

  • 21. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
    Eldweik L; Mantagos IS
    Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
    Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
    Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinopathy of prematurity.
    Jordan CO
    Pediatr Clin North Am; 2014 Jun; 61(3):567-77. PubMed ID: 24852153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.
    Sato T; Kusaka S; Shimojo H; Fujikado T
    Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eyesight to the Blind-Pharmacotherapy for Retinopathy of Prematurity.
    McPherson C
    Neonatal Netw; 2023 Mar; 42(2):88-95. PubMed ID: 36868806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of retinopathy of prematurity.
    Fleck BW
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F454-6. PubMed ID: 23813885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fluctuation of oxygenation and time spent in the target range on retinopathy of prematurity in extremely low birth weight infants.
    Das A; Mhanna M; Sears J; Houdek JW; Kumar N; Gunzler D; Einstadter D; Collin M
    J Neonatal Perinatal Med; 2018; 11(3):257-263. PubMed ID: 30103354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinopathy of prematurity in Indonesia: Incidence and risk factors.
    Edy Siswanto J; Sauer PJ
    J Neonatal Perinatal Med; 2017; 10(1):85-90. PubMed ID: 28304327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.
    Löfqvist C; Andersson E; Sigurdsson J; Engström E; Hård AL; Niklasson A; Smith LE; Hellström A
    Arch Ophthalmol; 2006 Dec; 124(12):1711-8. PubMed ID: 17159030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.
    Wright KW; Sami D; Thompson L; Ramanathan R; Joseph R; Farzavandi S
    Trans Am Ophthalmol Soc; 2006; 104():78-84. PubMed ID: 17471328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinopathy of prematurity outcome in infants with prethreshold retinopathy of prematurity and oxygen saturation >94% in room air: the high oxygen percentage in retinopathy of prematurity study.
    McGregor ML; Bremer DL; Cole C; McClead RE; Phelps DL; Fellows RR; Oden N;
    Pediatrics; 2002 Sep; 110(3):540-4. PubMed ID: 12205257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A paradigm shift in the prevention of retinopathy of prematurity.
    Raghuveer TS; Bloom BT
    Neonatology; 2011; 100(2):116-29. PubMed ID: 21372594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iris rubeosis, severe respiratory failure and retinopathy of prematurity--case report.
    Modrzejewska M; Kulik U; Lubiński W
    Ginekol Pol; 2014 Jan; 85(1):70-3. PubMed ID: 24505969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
    Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
    Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinopathy of Prematurity: Pathogenesis and Current Treatment Options.
    Quimson SK
    Neonatal Netw; 2015; 34(5):284-7. PubMed ID: 26802829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging treatments for retinopathy of prematurity.
    Mantagos IS; Vanderveen DK; Smith LE
    Semin Ophthalmol; 2009; 24(2):82-6. PubMed ID: 19373691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.